Cost of childhood cancer treatment in Ethiopia

Mizan Kiros Mirutse1,2, Michael Tekle Palm3, Mieraf Taddesse Tolla1

  • 1Department of Global Public Health and Primary Care, Bergen Centre for Ethics and Priority Setting (BCEPS), University of Bergen, Bergen, Norway.

Plos One
|June 2, 2023
PubMed

Insights

The annual cost to run Ethiopia's pediatric oncology unit was USD 776,060, or USD 577 per child. Childhood cancer treatment in Ethiopia appears affordable, warranting further cost-effectiveness studies.

Area of Science:

  • Health Economics
  • Pediatric Oncology
  • Public Health Policy

Background:

  • Ethiopia's National Childhood and Adolescent Cancer Control Plan (NCACCP) highlights the need to expand pediatric oncology services.
  • There is limited data on the operational costs of pediatric oncology units and childhood cancer treatment in Ethiopia.

Purpose of the Study:

  • To estimate the total annual cost of operating a pediatric oncology unit.
  • To determine the cost per treated child and per specific service (e.g., outpatient visit, bed day).

Main Methods:

  • A mixed (top-down and bottom-up) costing approach was used from a provider perspective.
  • Historical cost data and service quantities were collected for a pediatric oncology unit and other hospital departments over one year.
  • Direct costs (personnel, drugs, supplies, equipment) and overheads were aggregated to calculate total and unit costs.

Main Results:

  • The total annual cost for the pediatric oncology unit was USD 776,060 (USD 577 per child).
  • Cost per treated child varied from USD 469 to USD 1,085 based on sensitivity analysis.
  • Drugs/supplies (33%) and human resources (27%) were major cost drivers; inpatient care constituted 63% of costs.

Conclusions:

  • Operating a pediatric oncology unit in Ethiopia is likely affordable.
  • Further research on cost-effectiveness, equity, and financial protection is recommended to guide childhood cancer control interventions.
Abstract

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
364
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K